Merck · 23 hours ago
Associate Director, Payer Marketing, Respiratory
Merck is dedicated to delivering breakthrough innovations that improve the lives of respiratory patients worldwide. The Associate Director Payer Marketing role will lead the development and execution of payer marketing and market access strategies for the company's respiratory portfolio, collaborating with various stakeholders to achieve key business objectives.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Develop and execute strategies and tactics to attain profitable market access
Identify unmet evidence needs and access drivers to help inform HEOR, RWE, and broader evidence-generation plans
Define and monitor KPIs to assess the effectiveness of market access and payer marketing strategies
Support L3 initiatives for the BU including Global, Brand and Payer focused workstreams by providing US Payer perspective and insights
Serve as a core member in key workstreams such as V&I, PAT, and 4th Hurdle, ensuring alignment and integration of access perspectives
Partner closely with Brand Marketing, Field Access, Policy, Medical Affairs, Finance, and other stakeholders to align on strategy and execution
Lead market research efforts for in-line and pipeline respiratory assets to deepen understanding of the evolving access landscape, customer needs, and competitive environment
Conduct internal and external benchmarking to ensure the respiratory business is leveraging best-in-class market access and payer marketing practices
Lead budget and profit-plan activities for Market Access related to the product and broader respiratory initiatives
Identify unmet evidence needs and access drivers to inform HEOR, RWE, and broader evidence-generation plans
Qualification
Required
BA/BS Degree
Minimum of 3-5 years combined market access or payer reimbursement experience (healthcare industry experience, marketing/field leadership, account management or other customer-facing role, or consulting in the healthcare industry)
Demonstrated understanding of the mechanics and economics of the healthcare ecosystem, including influences across payer segments, distribution models and channel dynamics
Expertise in influencing without direct authority, navigating complex or matrix organizations, and successfully collaborating with cross-functional teams
Ability to learn quickly and to assess a variety of scenarios, strategically and operationally
Strong collaboration, with 'Win as one team' mindset
Strong knowledge of marketing principles, with ability to leverage data analytics and activate market research for insights
Brand Marketing
Chronic Obstructive Pulmonary Disease (COPD)
Collaboration
Data Analysis
Market Access
Marketing
Marketing Strategies
Market Research
Payer Marketing
Strategic Planning
Strategic Thinking
Preferred
Pharm D, MPH, MBA, or other advanced degree
Proven understanding of patient access mechanics, including the intersection of patient access and payer reimbursement
Extensive knowledge of marketing processes and ability to translate market trends and customer needs into resources or tactics
Previous experience in COPD (chronic obstructive pulmonary disease) or chronic conditions
Ability to create solutions that drive value for customers, incorporating innovative approaches where relevant
Working knowledge of agile environments with scrum principles
Exceptional leadership and communication skills
Proven success in establishing, developing, and maintaining business relationships
Strong collaboration, project management, and organizational skills; ability to prioritize activities and manage multiple tasks within deadlines
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital Advisors"Gavi, the Vaccine Alliance"
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-02-05
Genetic Engineering News
2026-02-05
Company data provided by crunchbase